共 12 条
[1]
Baughman R.P., Lower E.E., Du Bois R.M., Sarcoidosis, Lancet, 361, pp. 1111-1118, (2003)
[2]
Iannuzzi M.C., Rybicki B.A., Teirstein A.S., Sarcoidosis, N Engl J Med, 357, pp. 2153-2165, (2007)
[3]
Giuffrida T.J., Kerdel F.A., Sarcoidosis, Dermatol Clin, 20, pp. 435-447, (2002)
[4]
Handa R., Aggarwal P., Wali J.P., Wig N., Dinda A.K., Biswas A., Sarcoidosis presenting with peripheral lymphadenopathy, Sarcoidosis Vasc Diffuse Lung Dis, 15, (1998)
[5]
Saltini C., Crystal R.G., Pulmonary sarcoidosis: Pathogenesis, staging and therapy, Int Arch Allergy Appl Immunol, 76, SUPPL. 1, pp. 92-100, (1985)
[6]
Newman L.S., Rose C.S., Bresnitz E.A., Rossman M.D., Barnard J., Frederick M., Et al., A case control etiologic study of sarcoidosis: Environmental and occupational risk factors, Am J Respir Crit Care Med, 170, pp. 1324-1330, (2004)
[7]
Knopf A., Lahmer T., Chaker A., Stark T., Hofauer B., Pickhard A., Et al., Head and neck sarcoidosis, from wait and see to tumor necrosis factor alpha therapy: A pilot study, Head Neck, 35, pp. 715-719, (2013)
[8]
Daien C.I., Monnier A., Claudepierre P., Constantin A., Eschard J.P., Houvenagel E., Et al., Sarcoid-like granulomatosis in patients treated with tumor necrosis factor blockers: 10 Cases, Rheumatology, 48, pp. 883-886, (2009)
[9]
Fehrenbach H., Zissel G., Goldmann T., Tschernig T., Vollmer E., Pabst R., Et al., Alveolar macrophages are the main source for tumour necrosis factor-alpha in patients with sarcoidosis, Eur Respir J, 21, pp. 421-428, (2003)
[10]
Limper A.H., Colby T.V., Sanders M.S., Asakura S., Roche P.C., DeRemee R.A., Immunohistochemical localization of transforming growth factor-beta 1 in the nonnecrotizing granulomas of pulmonary sarcoidosis, Am J Respir Crit Care Med, 149, pp. 197-204, (1994)